CClinicalTrials.gg
CompletedNCT05740865Updated Apr 4, 2023

Risk Factors Associated With Infection After Spine Surgery

An observational study in Deep Surgical Site Infection and Spine Surgery, sponsored by Xuanwu Hospital, Beijing. Completed at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-04-04.

Sponsored by Xuanwu Hospital, Beijing · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
3,419
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Surgical site infection (SSI), particularly deep SSI, is one of the most serious complications after spinal surgery. evaluating the risk of SSI and, correspondingly, prescription of prophylactic measures are extremely important to prevent SSI and avoid potentially devastating consequences. A retrospective study was conducted aiming to develop a point-based prediction model of deep surgical site infection in patients receiving open posterior instrumented thoracolumbar surgery.

Read the detailed description

Data of 3,419 patients in 4 hospitals from Jan 1, 2012 to Dec 30, 2021 were retrospectively collected and were evaluated aiming to develop a point-based prediction model of deep surgical site infection in patients receiving open posterior instrumented thoracolumbar surgery. Clinical knowledge-driven, data-driven and decision tree model was used to identify predictive variables of deep SSI. Internal validation was performed by using bootstrapping methods.

02

Conditions studied

  • Deep Surgical Site Infection
  • Spine Surgery
03

In context

Infections

6,688 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's enrollment of 3,419 is above the median of 240 across 2,136 observational studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Xuanwu Hospital, Beijing is the lead sponsor of 346 studies on the registry; 217 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Study population included patients who previously receceived open posterior instrumented thoracolumbar surgery due to spine disease (except that spine infection or revision surgery)

Inclusion criteria

patients who previously received open posterior instrumented thoracolumbar surgery

Exclusion criteria

Exclusion Criteria:

  1. were aged \< 18 years;
  2. underwent surgery for the spinal infection, spine revision surgery, or cervical operation;
  3. were diagnosed as superficial SSI;
  4. died in hospital;
  5. diagnosis of SSI was not determined;
  6. had missing data more than 10% were excluded.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
3,419 participants (actual)
Patient registry
No

Groups and cohorts

  • patients who developed deep surgical site infection after thoracolumbar surgery

    this group included patients who developed deep surgical site infection after open posterior instrumented thoracolumbar surgery

    Procedure: open posterior instrumented thoracolumbar surgery

  • patients who did not develop deep surgical site infection after thoracolumbar surgery

    this group included patients who did not develop deep surgical site infection after open posterior instrumented thoracolumbar surgery

    Procedure: open posterior instrumented thoracolumbar surgery

Interventions

  • Procedureopen posterior instrumented thoracolumbar surgery

    Both group previously received open posterior instrumented thoracolumbar surgery in 4 centers

06

What researchers measure

Primary outcomes

  1. deep surgical site infection

    deep SSI was defined as an infection occurring within 30 days after the operation involving deep soft tissues along with one of the following criterion: (1)purulent drainage from the deep incision but not from the organ/space component of the surgical site;(2) a deep incision spontaneously dehisces or is deliberately opened by a surgeon when the patient has at least one of the following signs or symptoms: fever \>38℃, localized pain, or tenderness, unless site is culture-negative;(3) an abscess or other evidence of infection involving the deep incision is found on direct examination, during reoperation, or by histopathologic or radiologic examination;(4) diagnosis of a deep incisional SSI by a surgeon or attending physician. In this study, organ space SSI was also classified as deep SSI due to the same criteria as deep SSI.

    Time frame: within 30 days after the operation

07

Study locations

1 site
  • Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University
    Beijing, 100053, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05740865
Lead sponsor
Xuanwu Hospital, Beijing
Responsible party
Sponsor
First posted
Feb 23, 2023
Start date
Jan 1, 2012
Primary completion
Dec 31, 2021
Completion
Jan 20, 2023
Last update
Apr 4, 2023

Study contacts

Fengzeng Jian
study director · Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion